These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 23870513)

  • 21. Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer.
    Yang C; Chen H; Yu L; Shan L; Xie L; Hu J; Chen T; Tan Y
    Cancer Gene Ther; 2013 Feb; 20(2):117-24. PubMed ID: 23306612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.
    Liu Y; Hock JM; Van Beneden RJ; Li X
    Mol Carcinog; 2014 May; 53(5):380-91. PubMed ID: 23255470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of metformin on FOXM1 expression and on the biological behavior of acute leukemia cell lines.
    Zhang B; Liu LL; Mao X; Zhang DH
    Mol Med Rep; 2014 Dec; 10(6):3193-8. PubMed ID: 25310131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
    Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
    J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
    Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
    Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells.
    Miao L; Xiong X; Lin Y; Cheng Y; Lu J; Zhang J; Cheng N
    Cancer Genet; 2014 Mar; 207(3):75-82. PubMed ID: 24726291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells.
    Wang Z; Banerjee S; Kong D; Li Y; Sarkar FH
    Cancer Res; 2007 Sep; 67(17):8293-300. PubMed ID: 17804744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells.
    Bergamaschi A; Madak-Erdogan Z; Kim YJ; Choi YL; Lu H; Katzenellenbogen BS
    Breast Cancer Res; 2014 Sep; 16(5):436. PubMed ID: 25213081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
    Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
    Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXM1: A key oncofoetal transcription factor in health and disease.
    Bella L; Zona S; Nestal de Moraes G; Lam EW
    Semin Cancer Biol; 2014 Dec; 29():32-9. PubMed ID: 25068996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXM1: From cancer initiation to progression and treatment.
    Koo CY; Muir KW; Lam EW
    Biochim Biophys Acta; 2012 Jan; 1819(1):28-37. PubMed ID: 21978825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
    Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
    Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
    Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM
    Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
    Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
    Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
    Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
    Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
    Wang T; Liu Z; Shi F; Wang J
    Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.
    Feng J; Wang X; Zhu W; Chen S; Feng C
    Biochemistry (Mosc); 2017 Jun; 82(6):707-714. PubMed ID: 28601080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
    Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
    Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting FOXM1 in cancer.
    Halasi M; Gartel AL
    Biochem Pharmacol; 2013 Mar; 85(5):644-652. PubMed ID: 23103567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
    Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
    Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.